Copyright Reports & Markets. All rights reserved.

Global CAR T-cell Therapy Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of CAR T-cell Therapy Drug by Type
    • 1.3.1 Overview: Global CAR T-cell Therapy Drug Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global CAR T-cell Therapy Drug Consumption Value Market Share by Type in 2024
    • 1.3.3 CD19-targeted
    • 1.3.4 BCMA-targeted
  • 1.4 Global CAR T-cell Therapy Drug Market by Application
    • 1.4.1 Overview: Global CAR T-cell Therapy Drug Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Lymphoma
    • 1.4.3 Multiple Myeloma
  • 1.5 Global CAR T-cell Therapy Drug Market Size & Forecast
  • 1.6 Global CAR T-cell Therapy Drug Market Size and Forecast by Region
    • 1.6.1 Global CAR T-cell Therapy Drug Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global CAR T-cell Therapy Drug Market Size by Region, (2020-2031)
    • 1.6.3 North America CAR T-cell Therapy Drug Market Size and Prospect (2020-2031)
    • 1.6.4 Europe CAR T-cell Therapy Drug Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific CAR T-cell Therapy Drug Market Size and Prospect (2020-2031)
    • 1.6.6 South America CAR T-cell Therapy Drug Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa CAR T-cell Therapy Drug Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis CAR T-cell Therapy Drug Product and Solutions
    • 2.1.4 Novartis CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Novartis Recent Developments and Future Plans
  • 2.2 Gilead Sciences
    • 2.2.1 Gilead Sciences Details
    • 2.2.2 Gilead Sciences Major Business
    • 2.2.3 Gilead Sciences CAR T-cell Therapy Drug Product and Solutions
    • 2.2.4 Gilead Sciences CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Gilead Sciences Recent Developments and Future Plans
  • 2.3 Bristol-Myers Squibb
    • 2.3.1 Bristol-Myers Squibb Details
    • 2.3.2 Bristol-Myers Squibb Major Business
    • 2.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Product and Solutions
    • 2.3.4 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.4 J & J
    • 2.4.1 J & J Details
    • 2.4.2 J & J Major Business
    • 2.4.3 J & J CAR T-cell Therapy Drug Product and Solutions
    • 2.4.4 J & J CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 J & J Recent Developments and Future Plans
  • 2.5 JW Therapeutics
    • 2.5.1 JW Therapeutics Details
    • 2.5.2 JW Therapeutics Major Business
    • 2.5.3 JW Therapeutics CAR T-cell Therapy Drug Product and Solutions
    • 2.5.4 JW Therapeutics CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 JW Therapeutics Recent Developments and Future Plans
  • 2.6 FOSUNKite
    • 2.6.1 FOSUNKite Details
    • 2.6.2 FOSUNKite Major Business
    • 2.6.3 FOSUNKite CAR T-cell Therapy Drug Product and Solutions
    • 2.6.4 FOSUNKite CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 FOSUNKite Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global CAR T-cell Therapy Drug Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of CAR T-cell Therapy Drug by Company Revenue
    • 3.2.2 Top 3 CAR T-cell Therapy Drug Players Market Share in 2024
    • 3.2.3 Top 6 CAR T-cell Therapy Drug Players Market Share in 2024
  • 3.3 CAR T-cell Therapy Drug Market: Overall Company Footprint Analysis
    • 3.3.1 CAR T-cell Therapy Drug Market: Region Footprint
    • 3.3.2 CAR T-cell Therapy Drug Market: Company Product Type Footprint
    • 3.3.3 CAR T-cell Therapy Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global CAR T-cell Therapy Drug Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global CAR T-cell Therapy Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global CAR T-cell Therapy Drug Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global CAR T-cell Therapy Drug Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America CAR T-cell Therapy Drug Consumption Value by Type (2020-2031)
  • 6.2 North America CAR T-cell Therapy Drug Market Size by Application (2020-2031)
  • 6.3 North America CAR T-cell Therapy Drug Market Size by Country
    • 6.3.1 North America CAR T-cell Therapy Drug Consumption Value by Country (2020-2031)
    • 6.3.2 United States CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 6.3.3 Canada CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe CAR T-cell Therapy Drug Consumption Value by Type (2020-2031)
  • 7.2 Europe CAR T-cell Therapy Drug Consumption Value by Application (2020-2031)
  • 7.3 Europe CAR T-cell Therapy Drug Market Size by Country
    • 7.3.1 Europe CAR T-cell Therapy Drug Consumption Value by Country (2020-2031)
    • 7.3.2 Germany CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 7.3.3 France CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 7.3.5 Russia CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 7.3.6 Italy CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific CAR T-cell Therapy Drug Market Size by Region
    • 8.3.1 Asia-Pacific CAR T-cell Therapy Drug Consumption Value by Region (2020-2031)
    • 8.3.2 China CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 8.3.3 Japan CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 8.3.5 India CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 8.3.7 Australia CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America CAR T-cell Therapy Drug Consumption Value by Type (2020-2031)
  • 9.2 South America CAR T-cell Therapy Drug Consumption Value by Application (2020-2031)
  • 9.3 South America CAR T-cell Therapy Drug Market Size by Country
    • 9.3.1 South America CAR T-cell Therapy Drug Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa CAR T-cell Therapy Drug Market Size by Country
    • 10.3.1 Middle East & Africa CAR T-cell Therapy Drug Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)
    • 10.3.4 UAE CAR T-cell Therapy Drug Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 CAR T-cell Therapy Drug Market Drivers
  • 11.2 CAR T-cell Therapy Drug Market Restraints
  • 11.3 CAR T-cell Therapy Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 CAR T-cell Therapy Drug Industry Chain
  • 12.2 CAR T-cell Therapy Drug Upstream Analysis
  • 12.3 CAR T-cell Therapy Drug Midstream Analysis
  • 12.4 CAR T-cell Therapy Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global CAR T-cell Therapy Drug market size was valued at US$ 5337 million in 2024 and is forecast to a readjusted size of USD 31500 million by 2031 with a CAGR of 29.2% during review period.
    Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
    The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patient"s own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments.
    This report is a detailed and comprehensive analysis for global CAR T-cell Therapy Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global CAR T-cell Therapy Drug market size and forecasts, in consumption value ($ Million), 2020-2031
    Global CAR T-cell Therapy Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global CAR T-cell Therapy Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global CAR T-cell Therapy Drug market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for CAR T-cell Therapy Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global CAR T-cell Therapy Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    CAR T-cell Therapy Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    CD19-targeted
    BCMA-targeted
    Market segment by Application
    Lymphoma
    Multiple Myeloma
    Market segment by players, this report covers
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe CAR T-cell Therapy Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of CAR T-cell Therapy Drug, with revenue, gross margin, and global market share of CAR T-cell Therapy Drug from 2020 to 2025.
    Chapter 3, the CAR T-cell Therapy Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and CAR T-cell Therapy Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of CAR T-cell Therapy Drug.
    Chapter 13, to describe CAR T-cell Therapy Drug research findings and conclusion.

    Buy now